CUSIP 05464T104 · who reports it, how much, and how much it matters to them
56 of the 720 hedge fund managers we track reported shares of Axsome Therapeutics, Inc. (Nasdaq: AXSM) on Form 13F for 30 June 2026. Between them they reported USD 1.4bn. The largest position belongs to Deep Track Capital, at USD 171m. The manager with the most riding on it is Superstring Capital Management, where it is 8.3% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Deep Track Capital1 fund on PPLI.com | USD 171m | 2.5% |
| 2 | Two Sigma Investments35 funds on PPLI.com | USD 164m | 0.1% |
| 3 | D. E. Shaw & Co.15 funds on PPLI.com | USD 148m | 0.1% |
| 4 | Millennium Management6 funds on PPLI.com | USD 136m | 0.0% |
| 5 | POINT72 Asset Management17 funds on PPLI.com | USD 102m | 0.1% |
| 6 | Renaissance Technologies13 funds on PPLI.com | USD 64m | 0.1% |
| 7 | Adage Capital Management1 fund on PPLI.com | USD 63m | 0.1% |
| 8 | Citadel Advisors32 funds on PPLI.com | USD 63m | 0.0% |
| 9 | Samlyn Capital8 funds on PPLI.com | USD 60m | 1.0% |
| 10 | Marshall Wace LLP84 funds on PPLI.com | USD 55m | 0.0% |
| 11 | PFM Health Sciences3 funds on PPLI.com | USD 54m | 4.6% |
| 12 | Sofinnova Investments1 fund on PPLI.com | USD 39m | 2.0% |
| 13 | Squarepoint Ops7 funds on PPLI.com | USD 38m | 0.0% |
| 14 | Perceptive Advisors6 funds on PPLI.com | USD 29m | 0.4% |
| 15 | Orbimed Advisors1 fund on PPLI.com | USD 29m | 0.5% |
| 16 | Voleon Capital Management13 funds on PPLI.com | USD 21m | 0.4% |
| 17 | Weiss Asset Management5 funds on PPLI.com | USD 20m | 0.2% |
| 18 | Balyasny Asset Management25 funds on PPLI.com | USD 19m | 0.0% |
| 19 | Eagle Health Investments1 fund on PPLI.com | USD 16m | 2.6% |
| 20 | Atika Capital Management3 funds on PPLI.com | USD 15m | 1.0% |
| 21 | Bridgewater Associates45 funds on PPLI.com | USD 14m | 0.1% |
| 22 | Superstring Capital Management1 fund on PPLI.com | USD 13m | 8.3% |
| 23 | Panoramic Capital4 funds on PPLI.com | USD 11m | 4.6% |
| 24 | Hudson Bay Capital Management8 funds on PPLI.com | USD 11m | 0.0% |
| 25 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 8.7m | 0.0% |
| 26 | Brevan Howard Capital Management39 funds on PPLI.com | USD 7.8m | 0.1% |
| 27 | Jain Global1 fund on PPLI.com | USD 6.7m | 0.0% |
| 28 | J. Goldman & Co.1 fund on PPLI.com | USD 5.6m | 0.1% |
| 29 | HighVista Strategies27 funds on PPLI.com | USD 4.9m | 1.1% |
| 30 | Tudor Investment Corporation10 funds on PPLI.com | USD 4.6m | 0.0% |
| 31 | Ally Bridge Group (Ny)3 funds on PPLI.com | USD 4m | 3.6% |
| 32 | Aquatic Capital Management3 funds on PPLI.com | USD 4m | 0.1% |
| 33 | Atom Investors1 fund on PPLI.com | USD 3.5m | 0.3% |
| 34 | Engineers Gate Manager1 fund on PPLI.com | USD 2.7m | 0.0% |
| 35 | Cinctive Capital Management5 funds on PPLI.com | USD 2.7m | 0.1% |
| 36 | Lighthouse Investment Partners190 funds on PPLI.com | USD 2.6m | 0.1% |
| 37 | Neo Ivy Capital Management1 fund on PPLI.com | USD 2.5m | 0.6% |
| 38 | Edgestream Partners5 funds on PPLI.com | USD 2.1m | 0.1% |
| 39 | Boothbay Fund Management2 funds on PPLI.com | USD 1.6m | 0.0% |
| 40 | Fora Capital1 fund on PPLI.com | USD 1.6m | 0.1% |
| 41 | Verition Fund Management3 funds on PPLI.com | USD 1.5m | 0.0% |
| 42 | Rock Springs Capital Management2 funds on PPLI.com | USD 1.3m | 0.1% |
| 43 | LMR Partners2 funds on PPLI.com | USD 1.2m | 0.0% |
| 44 | Caxton Associates6 funds on PPLI.com | USD 1.1m | 0.0% |
| 45 | Diametric Capital2 funds on PPLI.com | USD 599,000 | 0.1% |
| 46 | The Quarry1 fund on PPLI.com | USD 490,000 | 0.0% |
| 47 | Walleye Capital8 funds on PPLI.com | USD 420,000 | 0.0% |
| 48 | CIBC Asset Management69 funds on PPLI.com | USD 387,000 | 0.0% |
| 49 | Persistent Asset Partners10 funds on PPLI.com | USD 385,000 | 0.1% |
| 50 | Prelude Capital Management9 funds on PPLI.com | USD 372,000 | 0.0% |
| 51 | Entrypoint Capital1 fund on PPLI.com | USD 340,000 | 0.1% |
| 52 | Mirabella Financial Services LLP10 funds on PPLI.com | USD 335,000 | 0.0% |
| 53 | BTG Pactual Asset Management US11 funds on PPLI.com | USD 320,000 | 0.0% |
| 54 | Dark Forest Capital Management2 funds on PPLI.com | USD 319,000 | 0.0% |
| 55 | Scientech Research2 funds on PPLI.com | USD 201,000 | 0.2% |
| 56 | Bayforest Capital1 fund on PPLI.com | USD 41,121 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Superstring Capital Management | USD 13m | 8.3% |
| 2 | Panoramic Capital | USD 11m | 4.6% |
| 3 | PFM Health Sciences | USD 54m | 4.6% |
| 4 | Ally Bridge Group (Ny) | USD 4m | 3.6% |
| 5 | Eagle Health Investments | USD 16m | 2.6% |
| 6 | Deep Track Capital | USD 171m | 2.5% |
| 7 | Sofinnova Investments | USD 39m | 2.0% |
| 8 | HighVista Strategies | USD 4.9m | 1.1% |
| 9 | Atika Capital Management | USD 15m | 1.0% |
| 10 | Samlyn Capital | USD 60m | 1.0% |
Axsome Therapeutics, Inc. trades under the symbol AXSM on the Nasdaq. Its CUSIP, the code used on Form 13F, is 05464T104.
56 of the 720 hedge fund managers PPLI.com tracks reported Axsome Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Deep Track Capital (USD 171m), Two Sigma Investments (USD 164m), D. E. Shaw & Co. (USD 148m), Millennium Management (USD 136m) and POINT72 Asset Management (USD 102m).
56 managers in our coverage reported it, and between them they run 794 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Superstring Capital Management, where the position was 8.3% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Axsome Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.